Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study

BACKGROUND: Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of cancers. We aimed to evaluate the incidence and prognostic impact of hepatic adverse events (AEs) in a territory‐wide cohort of patients who received ICIs. METHODS: Patients were identified from a territory‐wid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Chan, Stephen Lam, Yip, Terry Cheuk‐Fung, Wong, Vincent Wai‐Sun, Tse, Yee‐Kit, Yuen, Becky Wing‐Yan, Luk, Hester Wing‐Sum, Lui, Rashid Nok‐Shun, Chan, Henry Lik‐Yuen, Mok, Tony Shu‐Kam, Wong, Grace Lai‐Hung
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541136/
https://ncbi.nlm.nih.gov/pubmed/32780516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3378
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados